Alexander Campbell

Alexander Campbell is currently a Scientist II at Moonwalk Biosciences, focusing on developing a multi-modal platform for epigenome profiling since January 2024. Previously, at Synthego Corporation, Alexander worked in R&D, where responsibilities included verifying single guide RNA (sgRNA) sequences and developing analytical molecular assays. At Natera, as an Associate Scientist, Alexander led R&D projects on circulating tumor DNA (ctDNA) minimal residual disease (MRD) testing. Alexander's earlier experience includes roles at UPMC, where a clinical NGS assay for solid tumor cancers was validated, and at the National Institute of Allergy and Infectious Diseases, engaging in cutting-edge NGS applications in HIV research. Academic training includes a Master of Science in Molecular, Cellular, and Integrative Biosciences and a Bachelor of Science in Biology from Penn State University, with notable research contributions throughout the academic career.